Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Porton Fine Chemicals Pays $41.5 Million to Acquire Dongbang Pharma

publication date: Mar 11, 2015
Porton Fine Chemicals of Chongqing will acquire Jiangxi Dongbang Pharmaceutical Co., Ltd. for $41.5 million. Both companies are contract manufacturers of intermediates. The purchase will be paid with $16 million in cash and the remainder in stock. To pay for the acquisition, Porton raised as much as $11 million through a private placement. Founded in 2002 by returnees who worked at AkzoNobel, Porton specializes in chiral technology. More details....

Stock Symbol: (SHE: 300363)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital